The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Klukina L.A.
I.M. Sechenov First Moscow State Medical University
Sosnova E.A.
Sechenov First Moscow State University (Sechenov University)
Ischenko A.A.
Medical and Rehabilitation Center
Modern ideas about oncological aspects of ovulation induction in assisted reproductive technology programs in carriers of BRCA1/2 gene mutations
Journal: Russian Bulletin of Obstetrician-Gynecologist. 2022;22(4): 47‑54
Views: 1538
Downloaded: 22
To cite this article:
Klukina LA, Sosnova EA, Ischenko AA. Modern ideas about oncological aspects of ovulation induction in assisted reproductive technology programs in carriers of BRCA1/2 gene mutations. Russian Bulletin of Obstetrician-Gynecologist.
2022;22(4):47‑54. (In Russ.)
https://doi.org/10.17116/rosakush20222204147
Mutations in the BRCA1/2 genes are an independent and fundamental risk factor for breast cancer and ovarian cancer. The specifics of the effect of infertility treatment on the risk of developing cancer in carriers of mutations in the BRCA1/2 genes remain unclear and require a comprehensive study. In this review, we analyze published studies on the possible relationship between infertility treatment and the risk of ovarian and breast cancer in carriers of the BRCA1/2 mutation.
Keywords:
Authors:
Klukina L.A.
I.M. Sechenov First Moscow State Medical University
Sosnova E.A.
Sechenov First Moscow State University (Sechenov University)
Ischenko A.A.
Medical and Rehabilitation Center
Received:
16.11.2021
Accepted:
16.12.2021
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.